๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Induction of metallothionein mRNA by tumor promoters in mouse skin and its constitutive expression in papillomas

โœ Scribed by Hiroki Hashiba; Junichi Hosoi; Mika Karasawa; Shuhei Yamada; Kiyoshi Nose; Toshio Kuroki


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
566 KB
Volume
2
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

โœฆ Synopsis


A single topical application of 12-O-tetradecanoylphorbol-13-acetate (TPA) was found to induce mRNA of a metallothionein (MT) gene or genes in the skin of Sencar mice, and papillomas produced by repeated applications of TPA were shown to have elevated levels of MT mRNA. Induction of MT mRNA was maximal 4-8 h after application of TPA and returned to the control level 24 h later. A dose-dependent increase of MT mRNA was observed with doses of TPA of 1-5 micrograms. Of the other promoters tested, phorbol-12, 13-didecanoate, mezerein, and the ionophore A23187 also induced MT mRNA, but 4-O-methyl-TPA and benzoyl peroxide did not. Phorbol and 4 alpha-phorbol-12,13-didecanoate, which are not promoters, also did not induce MT mRNA. Retinoic acid and 1 alpha, 25-dihydroxyvitamin D3, inhibitors of tumor promotion, did not induce MT mRNA themselves or inhibit the induction of MT mRNA by TPA. In C57BL/6 promotion-resistant mice, TPA caused only slight induction of MT mRNA. These data suggest a correlation between induction of MT mRNA and epidermal hyperplasia. The constitutive elevation of MT mRNA levels in papillomas may be due to the loss, during the process of tumor promotion, of some mechanism regulating MT gene expression.


๐Ÿ“œ SIMILAR VOLUMES


Constitutive expression and induction of
โœ Dong-Young Ryu; Ernest Hodgson ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 64 KB ๐Ÿ‘ 1 views

Previous studies appeared to indicate that CYP1B1 was not constitutively expressed in mouse liver. In our laboratory, we demonstrated using aromatic hydrocarbon-responsive receptor knock-out (AHR --/-) mice that both piperonyl butoxide (PBO) and acenaphtyhlene (ACN) are AHR-independent inducers of m

Modulation of interleukin-1ฮฑ mRNA expres
โœ Wha Young Lee; Susan M. Fischer; Andrew P. Butler; Mary F. Locniskar ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 959 KB

## Abstract Increased expression of interleukinโ€1 (ILโ€1) in skin elicits a variety of responses, including inflammation and epidermal hyperplasia, which are also characteristic events elicited by tumor promoters. The goal of this study was to investigate whether various classes of tumor promoters i

Elevated expression of secondary, but no
โœ Yu Hashimoto; Osamu Tajima; Hiroki Hashiba; Kiyoshi Nose; Toshio Kuroki ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 755 KB

## Abstract A single topical treatment of mouse skin with the potent tumor promoter 12โ€Oโ€tetradecanoylphorbolโ€13โ€acetate (TPA) results in transient inductions of a variety of genes. Based on the time courses of their inductions, these genes can be classified into two main groups: โ€œearlyโ€ response g

Loss of critical palindromic transgene p
โœ Karol L. Thompson; Barry A. Rosenzweig; Ronald Honchel; Ronald E. Cannon; Kerry ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 311 KB

## Abstract The Tg.AC transgenic mouse carries a vโ€Haโ€__ras__ transgene. Skin papillomas develop in Tg.AC mice upon repeated dermal application of tumor promoters and carcinogens. The transgene is inserted at a single site on chromosome 11 in a multipleโ€copy array. Although most of the โ‰ฅโ€‰40 copies

Elevation of transforming growth factor-
โœ Kaoru Kiguchi; Linda M. Beltrรกn; Jinsong You; Okkyung Rho; John Digiovanni ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 908 KB

The study presented here was designed t o further investigate the role o f transforming growth factor-a (TGFa) in skin tumor promotion by examining the ability of 12-O-tetradecanoylphorbol-l3-acetate (TPA) and several non-phorbol ester promoters t o alter TGFa mRNA and protein levels in mouse epider

The development of contact hypersensitiv
โœ Brian Czerniecki; Gisela Witz; Christopher Reilly; Shayne C. Gad ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 847 KB

The ability of tumor promoters to suppress the development of contact hypersensitivity (CHS) was assessed by the mouse ear swelling assay. Application of the complete or second stage tumor promoters phorbol-12myristate-13-acetate (PMA, 2 pg), croton oil (1%). benzoyl peroxide (20 mg), mezerein ( 2 p